syncytin Inhibitors
Chemical class description of syncytin inhibitors is challenging due to the indirect nature of the compounds that affect syncytin function. These chemicals do not directly target syncytin but rather modulate cellular pathways that syncytin utilizes for its role in cell fusion. This array of compounds encompasses inhibitors of intracellular calcium signaling (BAPTA-AM, 2-APB, Anandamide, SKF-96365, KN-93, Xestospongin C), those affecting lipid metabolism and membrane composition (GW4869, D609), and others that influence endocytosis (Dynasore) or protein kinases involved in fusion processes (Rottlerin, ML-7). Each agent interacts with specific molecular targets-ranging from calcium channels to enzymes like nSMase and PKC-that are crucial for the intracellular events leading up to the fusion of cells, a process in which syncytin is a key participant.
The indirect inhibition strategy comes from the understanding that syncytin, while not being the primary target, is functionally dependent on various upstream and parallel pathways. These pathways converge on the regulation of intracellular calcium levels, membrane fluidity, and cytoskeletal dynamics, which are all essential for the fusogenic activity of syncytin. The chemical inhibitors listed can thus influence the activity of syncytin by creating an intracellular environment that is less conducive to the cell-cell fusion process. By adjusting the balance of signaling molecules and the cellular architecture, these inhibitors can disrupt the delicate orchestration of events that syncytin necessitates to facilitate its role in cell fusion. Each compound exerts its effects through well-defined molecular mechanisms that, while not exclusively designed to inhibit syncytin, converge on the regulatory processes that would result in its functional inhibition.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator that sequesters intracellular Ca²⁺. By lowering intracellular calcium levels, it indirectly inhibits syncytin-mediated cell fusion, which is calcium-dependent. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 is a neutral sphingomyelinase (nSMase) inhibitor that hampers the production of ceramide. Given that ceramide can modulate cell fusion events, GW4869 indirectly impacts syncytin by altering membrane lipid composition required for its fusogenic activity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small molecule that inhibits dynamin, a GTPase involved in endocytosis. As syncytin-mediated fusion may utilize endocytic machinery, dynasore can indirectly affect syncytin function by disrupting endocytosis. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB is an inhibitor of IP3 receptors and store-operated calcium entry (SOCE) channels, which are important for calcium homeostasis. It may indirectly affect syncytin activity by altering calcium signaling necessary for cell fusion. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 is an inhibitor of receptor-mediated calcium entry channels. It indirectly influences syncytin by impeding calcium signaling pathways integral to syncytin’s role in cell fusion. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin is a potent inhibitor of protein kinase C (PKC) that is known to regulate various cellular functions, including those related to viral fusion and entry. By inhibiting PKC, it could indirectly alter syncytin-mediated cell fusion. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of calcium/calmodulin-dependent protein kinase II (CaMKII), which is involved in the calcium signaling pathway. It may impact syncytin-mediated fusion by altering CaMKII activity. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $510.00 | 14 | |
Xestospongin C is an inhibitor of the IP3 receptor. By inhibiting this receptor, it disrupts calcium release from the endoplasmic reticulum, which could indirectly influence syncytin’s fusogenic function. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK), which plays a role in cell shape and structure. By influencing cell morphology, ML-7 might affect the syncytin-mediated cell fusion process indirectly. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
D609 is a phosphatidylcholine-specific phospholipase C inhibitor. It interferes with the generation of diacylglycerol (DAG) from phosphatidylcholine, which can alter cell membrane dynamics and potentially affect syncytin-mediated cell fusion. | ||||||